| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
43,910 |
36,240 |
$2.38M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,861 |
14,103 |
$1.18M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,937 |
2,892 |
$206K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,275 |
4,916 |
$185K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,274 |
1,265 |
$122K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
907 |
896 |
$92K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,131 |
710 |
$88K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
972 |
971 |
$84K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,202 |
476 |
$45K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
871 |
863 |
$41K |
| 99222 |
Initial hospital care, per day, moderate complexity |
470 |
450 |
$34K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,650 |
2,996 |
$30K |
| 90791 |
Psychiatric diagnostic evaluation |
254 |
254 |
$29K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
706 |
675 |
$28K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
206 |
205 |
$24K |
| 90674 |
|
726 |
721 |
$21K |
| 76942 |
|
800 |
749 |
$20K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,811 |
1,622 |
$19K |
| 94729 |
|
557 |
549 |
$13K |
| 94060 |
|
617 |
609 |
$13K |
| 99215 |
Prolong outpt/office vis |
143 |
130 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,082 |
1,062 |
$12K |
| 99441 |
|
394 |
369 |
$10K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,713 |
1,574 |
$10K |
| 87631 |
|
88 |
84 |
$8K |
| 93000 |
|
838 |
814 |
$7K |
| 20552 |
|
298 |
288 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
530 |
518 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
334 |
262 |
$6K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
64 |
63 |
$6K |
| 90661 |
|
154 |
153 |
$5K |
| 96130 |
|
92 |
64 |
$4K |
| 99406 |
|
388 |
381 |
$3K |
| 99223 |
Prolong inpt eval add15 m |
31 |
31 |
$3K |
| 99442 |
|
82 |
81 |
$3K |
| 94727 |
|
107 |
105 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
44 |
44 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,619 |
1,463 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,223 |
978 |
$2K |
| 81003 |
|
1,204 |
1,144 |
$2K |
| 95117 |
|
312 |
115 |
$2K |
| 94726 |
|
80 |
80 |
$1K |
| 99221 |
|
24 |
24 |
$1K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
63 |
26 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
413 |
405 |
$1K |
| 99233 |
Prolong inpt eval add15 m |
23 |
15 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
91 |
88 |
$1K |
| 90688 |
|
70 |
69 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13 |
13 |
$1K |
| 81025 |
|
148 |
146 |
$984.06 |
| 90686 |
|
56 |
55 |
$928.29 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
192 |
164 |
$788.70 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16 |
15 |
$684.08 |
| 96137 |
|
24 |
16 |
$666.76 |
| 92228 |
|
34 |
34 |
$534.24 |
| 96136 |
|
19 |
16 |
$464.44 |
| 99217 |
|
14 |
14 |
$455.25 |
| 71046 |
Radiologic examination, chest; 2 views |
32 |
28 |
$335.85 |
| 81002 |
|
134 |
127 |
$315.88 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
13 |
12 |
$272.58 |
| 82044 |
|
42 |
40 |
$187.99 |
| 94760 |
|
11,033 |
8,163 |
$106.76 |
| 98966 |
|
24 |
24 |
$44.30 |
| 3078F |
|
2,385 |
2,193 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
11,093 |
8,214 |
$0.00 |
| 1159F |
|
181 |
166 |
$0.00 |
| 3077F |
|
1,749 |
1,603 |
$0.00 |
| 2028F |
|
362 |
361 |
$0.00 |
| 3725F |
|
69 |
67 |
$0.00 |
| 3075F |
|
1,351 |
1,296 |
$0.00 |
| 3080F |
|
1,161 |
1,080 |
$0.00 |
| 3011F |
|
365 |
359 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
2,976 |
2,342 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
565 |
435 |
$0.00 |
| 3079F |
|
1,877 |
1,787 |
$0.00 |
| 3008F |
|
5,230 |
4,693 |
$0.00 |
| 3074F |
|
2,930 |
2,644 |
$0.00 |
| 2000F |
|
2,415 |
1,923 |
$0.00 |
| 1111F |
|
12 |
12 |
$0.00 |
| G9007 |
Coordinated care fee, scheduled team conference |
43 |
43 |
$0.00 |